(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
7.59% $ 12.49
Live Chart Being Loaded With Signals
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments...
Stats | |
---|---|
Dzisiejszy wolumen | 109.00 |
Średni wolumen | 190.00 |
Kapitalizacja rynkowa | 5.55B |
Last Dividend | $0.184 ( 2023-09-21 ) |
Next Dividend | $0 ( N/A ) |
P/E | 21.53 |
ATR14 | $0 (0.00%) |
Aspen Pharmacare Holdings Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Aspen Pharmacare Holdings Finanse
Annual | 2023 |
Przychody: | $2.29B |
Zysk brutto: | $1.02B (44.59 %) |
EPS: | $0.660 |
FY | 2023 |
Przychody: | $2.29B |
Zysk brutto: | $1.02B (44.59 %) |
EPS: | $0.660 |
FY | 2022 |
Przychody: | $2.54B |
Zysk brutto: | $1.15B (45.40 %) |
EPS: | $0.940 |
FY | 2021 |
Przychody: | $37.77B |
Zysk brutto: | $17.76B (47.03 %) |
EPS: | $10.53 |
Financial Reports:
No articles found.
Aspen Pharmacare Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.133 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0.184 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.101 | 2010-10-06 |
Last Dividend | $0.184 | 2023-09-21 |
Next Dividend | $0 | N/A |
Payout Date | 2023-10-11 | |
Next Payout Date | N/A | |
# dividends | 12 | -- |
Total Paid Out | $2.03 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.69 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.17 | |
Div. Directional Score | 7.90 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TTNDF | Ex Dividend Knight | 2023-08-29 | Annually | 0 | 0.00% | |
IVSBF | Ex Dividend Knight | 2023-11-03 | Annually | 0 | 0.00% | |
BDORY | Ex Dividend Knight | 2023-09-12 | Bi-Monthly | 0 | 0.00% | |
RBSFY | Ex Dividend Knight | 2023-06-09 | Annually | 0 | 0.00% | |
EMSHF | Ex Dividend Knight | 2023-08-15 | Annually | 0 | 0.00% | |
VWAPY | Ex Dividend Junior | 2023-05-11 | Annually | 0 | 0.00% | |
KTHN | Ex Dividend Knight | 2023-09-14 | Quarterly | 0 | 0.00% | |
CBCFF | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
SEBC | Ex Dividend Junior | 2023-08-30 | Quarterly | 0 | 0.00% | |
FOTB | Ex Dividend Junior | 2023-05-31 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.114 | 1.500 | 7.72 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0349 | 1.200 | 8.84 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0743 | 1.500 | -0.285 | -0.428 | [0.1 - 1] |
payoutRatioTTM | 0.315 | -1.000 | 6.85 | -6.85 | [0 - 1] |
currentRatioTTM | 1.918 | 0.800 | 5.41 | 4.33 | [1 - 3] |
quickRatioTTM | 1.053 | 0.800 | 8.51 | 6.81 | [0.8 - 2.5] |
cashRatioTTM | 0.505 | 1.500 | 8.30 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.259 | -1.500 | 5.68 | -8.52 | [0 - 0.6] |
interestCoverageTTM | 88.18 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 14.11 | 2.00 | 5.30 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 7.62 | 2.00 | 6.19 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.422 | -1.500 | 8.31 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.450 | 1.000 | 5.83 | 5.83 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.200 | 1.000 | 8.00 | 8.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.174 | 1.000 | -0.146 | -0.146 | [0.2 - 2] |
assetTurnoverTTM | 0.307 | 0.800 | -1.290 | -1.032 | [0.5 - 2] |
Total Score | 10.62 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 21.09 | 1.000 | 7.97 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0743 | 2.50 | -0.183 | -0.428 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 7.62 | 2.00 | 7.46 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.00419 | 1.500 | 9.90 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 14.11 | 2.00 | 5.30 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.315 | 1.500 | 6.85 | -6.85 | [0 - 1] |
pegRatioTTM | 0.0356 | 1.500 | -3.10 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.147 | 1.000 | 8.83 | 0 | [0.1 - 0.5] |
Total Score | 5.17 |
Aspen Pharmacare Holdings
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej